Buscar
15/11/2025
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
Hecht, JR, Park, YS, Tabernero, J, Lee, MA, Lee, SHY, Virgili, AC, van den Eynde, M, Fontana, E, Fakih, M, Asghari, G, So, JE, Stein, A, Dubreuil, O, Bodnar, L, He, CS, Wang, G, Smith, R, Eng, C, Saeed, A. Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial. LANCET. 2025; 406(10517)DOI:10.1016/S0140-6736(25)02025-2. PMID:41130252. IF:88.500(Q1/1D).
14/11/2025
Community-Onset Fungemias: Epidemiology and Genomic Characterization at a Tertiary-Care Hospital in Barcelona, Spain
Batista, CSP, Rivera, A, Albarran, MTA, Rubio, M, Belen-Figas, I, Lopez-Querol, C, Miro, E, Navarro, F, Sanchez-Reus, F. Community-Onset Fungemias: Epidemiology and Genomic Characterization at a Tertiary-Care Hospital in Barcelona, Spain. Journal Of Fungi. 2025; 11(11)DOI:10.3390/jof11110808. PMID:41295189. IF:4.000(Q1/1D).
12/11/2025
Mammographic density and breast cancer pathological subtypes by menopausal status and body mass index (vol 27, 187, 2025)
Fernández-Morata, J, Pollán, M, de Larrea-Baz, NF, Pachon-Olmos, V, García-Pérez, J, Castello, A, Sierra, MA, Lucas, P, Llobet, R, Stradella, A, Cantos, B, Cajal, TRY, Santisteban, M, Seguí, MA, Bertrán, AS, Granja, M, Camps-Herrero, J, Recalde, S, Nuñez-García, B, Verges, NC, Pérez-Gomez, B, Pastor-Barriuso, R, Lope, V. Mammographic density and breast cancer pathological subtypes by menopausal status and body mass index (vol 27, 187, 2025). BREAST CANCER RESEARCH. 2025; 27(1)DOI:10.1186/s13058-025-02169-5. PMID:41225573. IF:5.600(Q1/2D).
12/11/2025
CEB-01 membrane loaded with SN-38 for local post-resection control and metastasis reduction in preclinical pancreatic cancer models
Ninou, AH, Caruana, P, Marti, L, Tornero, J, De Llanos, EL, Casas, FC, de la Fuente, N, Aguilar-del Castillo, F, García-Sanchez, C, Cepeda-Franco, C, Padillo-Ruíz, J, Céspedes, MV. CEB-01 membrane loaded with SN-38 for local post-resection control and metastasis reduction in preclinical pancreatic cancer models. Drug Delivery and Translational Research. 2025; DOI:10.1007/s13346-025-02013-5. PMID:41225246. IF:5.500(Q1/1D).